I've Changed My Mind on Intel Stock. Here's What the AI Supercycle Bears Are Missing.

Intel posted 7% year-over-year revenue growth to $13.6 billion in fiscal Q1, with data center and AI sales up 22% to $5.1 billion and foundry revenue up 16% to $5.4 billion. The company also benefited from major strategic partnerships, including Nvidia and the Elon Musk-led Terafab project, while fiscal Q2 guidance calls for $13.8 billion to $14.8 billion in sales versus $12.9 billion a year ago. The article argues the AI upgrade cycle and Lip-Bu Tan's turnaround are improving Intel's long-term outlook, though it advises waiting for the stock's sharp run-up to cool.

Analysis

The market is repricing Intel less as a pure turnaround story and more as a scarce “AI capacity” proxy with domestic manufacturing optionality. That matters because the first derivative trade is no longer just better execution; it is multiple expansion driven by investors hunting beneficiaries of the AI capex cycle that are not already crowded into NVDA. The secondary effect is that every credible sign of foundry traction widens the moat around the U.S. supply chain narrative, which can pull in policy-sensitive capital even if end-demand decelerates.

The biggest underappreciated factor is that Intel’s upside is now tied to capacity credibility, not only product competitiveness. If customers believe Tan can actually deliver wafers on time, the company can win design-ins and multi-year commitments that lower earnings volatility and raise terminal value; if execution slips, the stock likely gives back a large portion of the recent move quickly because the rally has already discounted a meaningful amount of improvement. That makes the next 1-2 quarters more important than the next year: guidance, foundry mix, and any evidence of conversion from partnership headlines into revenue are the real catalysts.

The contrarian take is that this move may be partially over-extended relative to fundamentals because the stock is now trading on narrative compression, not just earnings power. The market seems to be conflating strategic relevance with near-term profitability, but foundry businesses usually monetize slowly and require sustained capex before margins inflect. In other words, the right way to be bullish is not to chase strength indiscriminately; it is to express a view that Intel’s operational reset will keep rerating, but only if the AI infrastructure cycle remains intact and management avoids any stumble on capacity ramps.

Key Decisions for Investors

• Use pullbacks, not breakouts, to build a tactical long INTC position over the next 2-6 weeks; target a retracement rather than chase the recent move, because the stock is already discounting multiple quarters of improvement.
• Pair trade: long INTC / short AMD for 1-3 months if you want to isolate foundry-policy and domestic-capacity optionality; the thesis is that Intel’s rerating has more room from a depressed base, while AMD is more exposed to a crowded AI-performer setup.
• Sell near-dated covered calls on INTC against any core long into the next earnings/guidance window; implied volatility should stay elevated, and the stock’s recent momentum makes premium capture attractive if the name stalls.
• For higher-conviction upside exposure, buy 3-6 month INTC call spreads rather than outright calls; this captures rerating potential while limiting downside if sentiment cools once the headline-driven phase ends.
• Monitor NVDA/INTC partnership updates as a catalyst basket: positive product detail should support both names, but a lack of concrete economics would be a warning sign to reduce INTC exposure quickly.